Chemical Structure (Duloxetine 01)
Duloxetine
Product Images NDC 50436-0747
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50436-0747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
The text describes a graph displaying the proportion of patients experiencing a relapse over time. The x-axis shows the time from randomization to relapse measured in days, while the y-axis shows the proportion of patients with relapse. Two treatments are compared: placebo and Duloxetine delayed-release capsules. The graph suggests that the treatment with Duloxetine may reduce the risk of relapse compared to placebo.*
Figure 2 (Duloxetine 03)
The given text seems to be a graph showing the Proportion of Patients with Relapse over time for two treatments - Placebo and Duloxetine delayed-release capsules. Time is represented in days and the proportion of patients is represented on the y-axis. The graph shows that patients on Duloxetine have a lower proportion of relapse over time compared to Placebo.*
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 8 (Duloxetine 08)
The text provides statistical data on the percentage of patients who have experienced improvement while taking placebo and DUL 60/120 mg once daily. The numbers "8 8 8 38 38 3 8 8 8" and "3" may represent the percentage of improved patients in different trials or time points. The graph shows the percent improvement in pain from baseline for different dosage levels ranging from 0 to 100. Therefore, this text could be useful for doctors or researchers who are evaluating the effectiveness of DUL for pain management.*
Figure 9 (Duloxetine 09)
The text describes a graph showing the percentage of patients improved after taking a placebo or 60mg of DUL once daily. The graph has 10 data points ranging from 50 to 100 on the X-axis and percentages on the Y-axis, with the placebo data represented by the symbol 'X' and the DUL data represented by '&'.*
Figure 10 (Duloxetine 10)
This text presents a graph showing the percentage of patients who improved after taking either a placebo or DUL60/120 mg once daily medication. The x-axis presents different percentages from 0 to 100, while the y-axis represents different levels of improvement from 0 to 80. Additionally, there is a chart with different values ranging from 0 to 10D. It seems to be related to the percentage of pain improvement from baseline, represented in BOCF.*
Label Image (Lbl504360747)
This is a description of a drug called Duloxetine Hydrochloride, in the form of delayed-release capsules, with a strength of 30 mg, and packed in a container. Each capsule contains 337 mg of Duloxetine Hydrochloride, which is equivalent to 30 mg of Duloxetine. The drug has a warning to keep it out of reach of children and store it at 25°C. The user should refer to the package insert for dosage information. The manufacturer is Breckenridge Pharm, located in Berlin, CT, with NDC and MFGLOT numbers provided. The text contains duplicates of the same information and is noisy, but can be interpreted as a pharmaceutical description.*
Label Image (Lbl504360748)
This is a description of a medication with NDC code 50436-074. The medication contains Duloxetine Hydrochloride, which is a delayed release capsule with 60mg per 30 capsules. It is manufactured by Breckenridge Pharma Inc (Berlin, CT). There are dosage instructions on the package insert and should be stored at controlled room temperature. The expiration date is labeled as XUDOXDX, and it is RX only. The rest of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
